Assetmark Inc. Boosts Holdings in HCA Healthcare, Inc. $HCA

Assetmark Inc. raised its holdings in HCA Healthcare, Inc. (NYSE:HCA) by 51.8% during the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 32,701 shares of the company’s stock after purchasing an additional 11,153 shares during the period. Assetmark Inc.’s holdings in HCA Healthcare were worth $15,476,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. State Street Corp increased its position in HCA Healthcare by 1.0% during the fourth quarter. State Street Corp now owns 7,566,643 shares of the company’s stock worth $3,532,563,000 after buying an additional 76,039 shares in the last quarter. Capital World Investors increased its position in HCA Healthcare by 0.8% during the 4th quarter. Capital World Investors now owns 4,999,422 shares of the company’s stock worth $2,334,040,000 after purchasing an additional 40,086 shares in the last quarter. Geode Capital Management LLC lifted its holdings in HCA Healthcare by 0.4% in the 4th quarter. Geode Capital Management LLC now owns 3,663,705 shares of the company’s stock valued at $1,702,738,000 after purchasing an additional 13,565 shares in the last quarter. Norges Bank purchased a new stake in shares of HCA Healthcare during the fourth quarter worth about $1,262,513,000. Finally, Arrowstreet Capital Limited Partnership lifted its stake in shares of HCA Healthcare by 11.9% during the fourth quarter. Arrowstreet Capital Limited Partnership now owns 2,311,112 shares of the company’s stock valued at $1,078,966,000 after buying an additional 245,887 shares during the period. Hedge funds and other institutional investors own 62.73% of the company’s stock.

Analyst Upgrades and Downgrades

Several brokerages have weighed in on HCA. Oppenheimer cut their price target on HCA Healthcare from $540.00 to $520.00 and set an “outperform” rating for the company in a report on Monday, April 27th. Royal Bank Of Canada reduced their target price on HCA Healthcare from $534.00 to $435.00 and set an “outperform” rating on the stock in a research report on Wednesday. Jefferies Financial Group set a $450.00 price target on HCA Healthcare in a report on Tuesday, July 14th. Deutsche Bank Aktiengesellschaft lowered their target price on shares of HCA Healthcare from $558.00 to $540.00 and set a “buy” rating for the company in a report on Tuesday, April 28th. Finally, Cantor Fitzgerald cut their price target on shares of HCA Healthcare from $588.00 to $525.00 and set an “overweight” rating on the stock in a research note on Tuesday, July 7th. Fourteen investment analysts have rated the stock with a Buy rating, nine have given a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat, HCA Healthcare currently has an average rating of “Moderate Buy” and an average price target of $486.14.

HCA Healthcare Trading Up 0.1%

Shares of NYSE HCA opened at $371.60 on Monday. HCA Healthcare, Inc. has a 12-month low of $330.00 and a 12-month high of $556.52. The stock has a fifty day moving average price of $392.25 and a 200 day moving average price of $456.93. The company has a market cap of $82.44 billion, a P/E ratio of 12.78, a P/E/G ratio of 1.23 and a beta of 1.12.

HCA Healthcare (NYSE:HCA) last posted its earnings results on Friday, April 24th. The company reported $7.15 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $7.19 by ($0.04). The company had revenue of $19.11 billion during the quarter, compared to analyst estimates of $19.09 billion. HCA Healthcare had a net margin of 8.89% and a negative return on equity of 295.93%. HCA Healthcare’s quarterly revenue was up 4.3% compared to the same quarter last year. During the same quarter last year, the business posted $6.45 EPS. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. On average, sell-side analysts forecast that HCA Healthcare, Inc. will post 29.73 EPS for the current fiscal year.

HCA Healthcare Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Tuesday, June 30th. Investors of record on Tuesday, June 16th were paid a dividend of $0.78 per share. The ex-dividend date of this dividend was Tuesday, June 16th. This represents a $3.12 annualized dividend and a yield of 0.8%. HCA Healthcare’s payout ratio is 10.73%.

About HCA Healthcare

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.